Literature DB >> 25600502

Germline RAD51B truncating mutation in a family with cutaneous melanoma.

Karin A W Wadt1, Lauren G Aoude, Lisa Golmard, Thomas V O Hansen, Xavier Sastre-Garau, Nicholas K Hayward, Anne-Marie Gerdes.   

Abstract

Known melanoma predisposition genes only account for around 40% of high-density melanoma families. Other rare mutations are likely to play a role in melanoma predisposition. RAD51B plays an important role in DNA repair through homologous recombination, and inactivation of RAD51B has been implicated in tumorigenesis. Thus RAD51B is a good candidate melanoma susceptibility gene, and previously, a germline splicing mutation in RAD51B has been identified in a family with early-onset breast cancer. In order to find genetic variants associated with melanoma predisposition, whole-exome sequencing was carried out on blood samples from a three-case cutaneous melanoma family. We identified a novel germline RAD51B nonsense mutation, and we demonstrate reduced expression of RAD51B in melanoma cells indicating inactivation of RAD51B. This is only the second report of a germline truncating RAD51B mutation. While this case report is consistent with melanoma being part of the RAD51B cancer spectrum further population-based screening of large case-control sample series will be needed to definitively establish if this is the case.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25600502     DOI: 10.1007/s10689-015-9781-4

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

1.  The Rad51 paralog Rad51B promotes homologous recombinational repair.

Authors:  M Takata; M S Sasaki; E Sonoda; T Fukushima; C Morrison; J S Albala; S M Swagemakers; R Kanaar; L H Thompson; S Takeda
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes.

Authors:  Kirk E Lohmueller; Thomas Sparsø; Qibin Li; Ehm Andersson; Thorfinn Korneliussen; Anders Albrechtsen; Karina Banasik; Niels Grarup; Ingileif Hallgrimsdottir; Kristoffer Kiil; Tuomas O Kilpeläinen; Nikolaj T Krarup; Tune H Pers; Gaston Sanchez; Youna Hu; Michael Degiorgio; Torben Jørgensen; Annelli Sandbæk; Torsten Lauritzen; Søren Brunak; Karsten Kristiansen; Yingrui Li; Torben Hansen; Jun Wang; Rasmus Nielsen; Oluf Pedersen
Journal:  Am J Hum Genet       Date:  2013-11-27       Impact factor: 11.025

3.  Isotypic neutralizing antibodies against mouse GCP-2/CXCL6 inhibit melanoma growth and metastasis.

Authors:  Hannelien Verbeke; Sofie Struyf; Nele Berghmans; Els Van Coillie; Ghislain Opdenakker; Catherine Uyttenhove; Jacques Van Snick; Jo Van Damme
Journal:  Cancer Lett       Date:  2011-01-13       Impact factor: 8.679

4.  Cancer risks in BRCA2 mutation carriers.

Authors: 
Journal:  J Natl Cancer Inst       Date:  1999-08-04       Impact factor: 13.506

5.  SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs.

Authors:  Petar N Grozdanov; Sujayita Roy; Nupur Kittur; U Thomas Meier
Journal:  RNA       Date:  2009-04-21       Impact factor: 4.942

6.  A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Authors:  Gilles Thomas; Kevin B Jacobs; Peter Kraft; Meredith Yeager; Sholom Wacholder; David G Cox; Susan E Hankinson; Amy Hutchinson; Zhaoming Wang; Kai Yu; Nilanjan Chatterjee; Montserrat Garcia-Closas; Jesus Gonzalez-Bosquet; Ludmila Prokunina-Olsson; Nick Orr; Walter C Willett; Graham A Colditz; Regina G Ziegler; Christine D Berg; Saundra S Buys; Catherine A McCarty; Heather Spencer Feigelson; Eugenia E Calle; Michael J Thun; Ryan Diver; Ross Prentice; Rebecca Jackson; Charles Kooperberg; Rowan Chlebowski; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Alice Sigurdson; Michele Doody; Parveen Bhatti; Bruce H Alexander; Julie Buring; I-Min Lee; Lars J Vatten; Kristian Hveem; Merethe Kumle; Richard B Hayes; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert N Hoover; Stephen J Chanock; David J Hunter
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

7.  POT1 loss-of-function variants predispose to familial melanoma.

Authors:  Carla Daniela Robles-Espinoza; Mark Harland; Andrew J Ramsay; Lauren G Aoude; Víctor Quesada; Zhihao Ding; Karen A Pooley; Antonia L Pritchard; Jessamy C Tiffen; Mia Petljak; Jane M Palmer; Judith Symmons; Peter Johansson; Mitchell S Stark; Michael G Gartside; Helen Snowden; Grant W Montgomery; Nicholas G Martin; Jimmy Z Liu; Jiyeon Choi; Matthew Makowski; Kevin M Brown; Alison M Dunning; Thomas M Keane; Carlos López-Otín; Nelleke A Gruis; Nicholas K Hayward; D Timothy Bishop; Julia A Newton-Bishop; David J Adams
Journal:  Nat Genet       Date:  2014-03-30       Impact factor: 38.330

8.  Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

Authors:  Lauren G Aoude; Antonia L Pritchard; Carla Daniela Robles-Espinoza; Karin Wadt; Mark Harland; Jiyeon Choi; Michael Gartside; Víctor Quesada; Peter Johansson; Jane M Palmer; Andrew J Ramsay; Xijun Zhang; Kristine Jones; Judith Symmons; Elizabeth A Holland; Helen Schmid; Vanessa Bonazzi; Susan Woods; Ken Dutton-Regester; Mitchell S Stark; Helen Snowden; Remco van Doorn; Grant W Montgomery; Nicholas G Martin; Thomas M Keane; Carlos López-Otín; Anne-Marie Gerdes; Håkan Olsson; Christian Ingvar; Ake Borg; Nelleke A Gruis; Jeffrey M Trent; Göran Jönsson; D Timothy Bishop; Graham J Mann; Julia A Newton-Bishop; Kevin M Brown; David J Adams; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

9.  Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk.

Authors:  Nick Orr; Alina Lemnrau; Rosie Cooke; Olivia Fletcher; Katarzyna Tomczyk; Michael Jones; Nichola Johnson; Christopher J Lord; Costas Mitsopoulos; Marketa Zvelebil; Simon S McDade; Gemma Buck; Christine Blancher; Alison H Trainer; Paul A James; Stig E Bojesen; Susanne Bokmand; Heli Nevanlinna; Johanna Mattson; Eitan Friedman; Yael Laitman; Domenico Palli; Giovanna Masala; Ines Zanna; Laura Ottini; Giuseppe Giannini; Antoinette Hollestelle; Ans M W van den Ouweland; Srdjan Novaković; Mateja Krajc; Manuela Gago-Dominguez; Jose Esteban Castelao; Håkan Olsson; Ingrid Hedenfalk; Douglas F Easton; Paul D P Pharoah; Alison M Dunning; D Timothy Bishop; Susan L Neuhausen; Linda Steele; Richard S Houlston; Montserrat Garcia-Closas; Alan Ashworth; Anthony J Swerdlow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

10.  A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers.

Authors:  Lauren G Aoude; Karin Wadt; Anders Bojesen; Dorthe Crüger; Ake Borg; Jeffrey M Trent; Kevin M Brown; Anne-Marie Gerdes; Göran Jönsson; Nicholas K Hayward
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  10 in total

Review 1.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

2.  DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.

Authors:  Barbara Pardini; Alda Corrado; Elisa Paolicchi; Giovanni Cugliari; Sonja I Berndt; Stephane Bezieau; Stephanie A Bien; Hermann Brenner; Bette J Caan; Peter T Campbell; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Michelle Cotterchio; Manish Gala; Steven J Gallinger; Robert W Haile; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; John L Hopper; Li Hsu; Jeroen Huyghe; Mark A Jenkins; Loic Le Marchand; Yi Lin; Noralane M Lindor; Hongmei Nan; Polly A Newcomb; Shuji Ogino; John D Potter; Robert E Schoen; Martha L Slattery; Emily White; Ludmila Vodickova; Veronika Vymetalkova; Pavel Vodicka; Federica Gemignani; Ulrike Peters; Alessio Naccarati; Stefano Landi
Journal:  Int J Cancer       Date:  2019-07-04       Impact factor: 7.316

Review 3.  Melanoma Risk and Melanocyte Biology.

Authors:  Julie U Bertrand; Eirikur Steingrimsson; Fanélie Jouenne; Brigitte Bressac-de Paillerets; Lionel Larue
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

4.  Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.

Authors:  Na Li; Simone M Rowley; Ella R Thompson; Simone McInerny; Lisa Devereux; Kaushalya C Amarasinghe; Magnus Zethoven; Richard Lupat; David Goode; Jason Li; Alison H Trainer; Kylie L Gorringe; Paul A James; Ian G Campbell
Journal:  Breast Cancer Res       Date:  2018-01-09       Impact factor: 6.466

Review 5.  Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.

Authors:  Rick Kamps; Rita D Brandão; Bianca J van den Bosch; Aimee D C Paulussen; Sofia Xanthoulea; Marinus J Blok; Andrea Romano
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

6.  Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.

Authors:  Thomas P Potjer; Sander Bollen; Anneliese J E M Grimbergen; Remco van Doorn; Nelleke A Gruis; Christi J van Asperen; Frederik J Hes; Nienke van der Stoep
Journal:  Int J Cancer       Date:  2019-01-21       Impact factor: 7.396

7.  Polymorphisms of homologous recombination RAD51, RAD51B, XRCC2, and XRCC3 genes and the risk of prostate cancer.

Authors:  Maria Nowacka-Zawisza; Ewelina Wiśnik; Andrzej Wasilewski; Milena Skowrońska; Ewa Forma; Magdalena Bryś; Waldemar Różański; Wanda M Krajewska
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-03       Impact factor: 2.916

8.  RAD51B in Familial Breast Cancer.

Authors:  Liisa M Pelttari; Sofia Khan; Mikko Vuorela; Johanna I Kiiski; Sara Vilske; Viivi Nevanlinna; Salla Ranta; Johanna Schleutker; Robert Winqvist; Anne Kallioniemi; Thilo Dörk; Natalia V Bogdanova; Jonine Figueroa; Paul D P Pharoah; Marjanka K Schmidt; Alison M Dunning; Montserrat García-Closas; Manjeet K Bolla; Joe Dennis; Kyriaki Michailidou; Qin Wang; John L Hopper; Melissa C Southey; Efraim H Rosenberg; Peter A Fasching; Matthias W Beckmann; Julian Peto; Isabel Dos-Santos-Silva; Elinor J Sawyer; Ian Tomlinson; Barbara Burwinkel; Harald Surowy; Pascal Guénel; Thérèse Truong; Stig E Bojesen; Børge G Nordestgaard; Javier Benitez; Anna González-Neira; Susan L Neuhausen; Hoda Anton-Culver; Hermann Brenner; Volker Arndt; Alfons Meindl; Rita K Schmutzler; Hiltrud Brauch; Thomas Brüning; Annika Lindblom; Sara Margolin; Arto Mannermaa; Jaana M Hartikainen; Georgia Chenevix-Trench; Laurien Van Dyck; Hilde Janssen; Jenny Chang-Claude; Anja Rudolph; Paolo Radice; Paolo Peterlongo; Emily Hallberg; Janet E Olson; Graham G Giles; Roger L Milne; Christopher A Haiman; Fredrick Schumacher; Jacques Simard; Martine Dumont; Vessela Kristensen; Anne-Lise Borresen-Dale; Wei Zheng; Alicia Beeghly-Fadiel; Mervi Grip; Irene L Andrulis; Gord Glendon; Peter Devilee; Caroline Seynaeve; Maartje J Hooning; Margriet Collée; Angela Cox; Simon S Cross; Mitul Shah; Robert N Luben; Ute Hamann; Diana Torres; Anna Jakubowska; Jan Lubinski; Fergus J Couch; Drakoulis Yannoukakos; Nick Orr; Anthony Swerdlow; Hatef Darabi; Jingmei Li; Kamila Czene; Per Hall; Douglas F Easton; Johanna Mattson; Carl Blomqvist; Kristiina Aittomäki; Heli Nevanlinna
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

9.  Genetic variants within microRNA-binding site of RAD51B are associated with risk of cervical cancer in Chinese women.

Authors:  Dong Hang; Wen Zhou; Meiqun Jia; Lihua Wang; Jing Zhou; Yin Yin; Hongxia Ma; Zhibin Hu; Ni Li; Hongbin Shen
Journal:  Cancer Med       Date:  2016-06-23       Impact factor: 4.452

10.  Founder Mutations for Early Onset Melanoma as Revealed by Whole Exome Sequencing Suggests That This is Not Associated with the Increasing Incidence of Melanoma in Poland.

Authors:  Tadeusz Dębniak; Rodney J Scott; Rodney A Lea; Bohdan Górski; Bartłomiej Masojć; Cezary Cybulski; Andrzej Kram; Romuald Maleszka; Tomasz Gromowski; Katarzyna Paszkowska-Szczur; Aniruddh Kashyap; Marcin R Lener; Karolina Malińska; Emilia Rogoża; Dawid Murawa; Helena Rudnicka; Jakub Deptuła; Jan Lubiński
Journal:  Cancer Res Treat       Date:  2018-05-14       Impact factor: 4.679

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.